Go to Samples

UCB, Inc.
BIMZELX
Two 160 mg/mL in single-dose autoinjectors
Indications and Usage
BIMZELX is a humanized interleukin-17A and F antagonist indicated for the treatment of:
- Moderate to severeplaque psoriasis (PSO)in adults who are candidates for systemic therapy or phototherapy. (
1.1) - Adults with activepsoriatic arthritis (PsA). (
1.2) - Adults with activenon-radiographic axial spondyloarthritis(nr-axSpA) with objective signs of inflammation. (
1.3) - Adults with activeankylosing spondylitis(AS). (
1.4) - Adults with moderate to severehidradenitis suppurativa (HS). (
1.5)
FAQs
All you need to know to order samples
Due to manufacturer restrictions, there are some limitations on the quantities of samples that can be included in each order. We're working on new functionality to let your practice place larger, batch orders.